Kanesa-thasan Niranjan
Officer at Icosavax, Inc.
- Sold, on record
- $1.9M
- Dollars the filings state
- Form 4 sales
- 5
- Latest Dec 20, 2023
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Icosavax, Inc.Officer
Sales by reason
Form 4 sales per year, every sale on record.
Timeline
- 1 Form 4 sale Icosavax, Inc.Plan not statedAug 2, 2022 2022
Sold 3,245 shares at $6.75 ($22k)
Kanesa-thasan Niranjan, Chief Medical Officer
Sold 1.3% of holdings ($1.6M position)239,314 shares leftFirst sale on recordFiling
- 2 Form 4 sale Icosavax, Inc.UnusualJan 4, 2023 +155 days
Sold 106,373 shares at $15.70 ($1.7M)
Kanesa-thasan Niranjan, Chief Medical Officer
No 10b5-1 planSold 32.2% of holdings ($5.2M position)223,980 shares leftFiling
- 3 Form 4 sale Icosavax, Inc.Plan not statedFeb 13, 2023 +40 days
Sold 1,794 shares at $10.69 ($19k)
Kanesa-thasan Niranjan, Chief Medical Officer
Sold 0.7% of holdings ($2.6M position)239,187 shares leftFiling
- 4 Form 4 sale Icosavax, Inc.RoutineJul 31, 2023 +168 days
Sold 3,323 shares at $8.86 ($29k)
Kanesa-thasan Niranjan, Chief Medical Officer
10b5-1 planSold 1.4% of holdings ($2.1M position)235,864 shares leftFiling
- 5 Form 144 notice Icosavax, Inc.NoticeDec 20, 2023 +142 days
Filed to sell 11,884 shares ($184k)
Kanesa-thasan Niranjan, Officer
10b5-1 plan3.6x usual sizeFiling
- 6 Form 4 sale Icosavax, Inc.UnusualDec 20, 2023 same day
Sold 11,884 shares at $15.46 ($184k)
Kanesa-thasan Niranjan, Chief Medical Officer
No 10b5-1 planSold 5% of holdings ($3.6M position)223,980 shares left3.7x usual sizeFollows a Form 144Filing
- 7 Form 144 notice Icosavax, Inc.NoticeJan 4, 2024 +15 days
Filed to sell 106,373 shares ($1.7M)
Kanesa-thasan Niranjan, Officer
No 10b5-1 plan32x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (7)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 4, 2024 | Jan 4, 2024 | Icosavax, Inc. | Officer | Form 144 notice | 106,373 | $1.7M | Notice | SEC | |
| Dec 20, 2023 | Dec 22, 2023 | Icosavax, Inc. | Chief Medical Officer | Form 4 sale | 11,884 | $184k | 5.0% | Unusual | SEC |
| Dec 20, 2023 | Dec 20, 2023 | Icosavax, Inc. | Officer | Form 144 notice | 11,884 | $184k | Notice | SEC | |
| Jul 31, 2023 | Aug 1, 2023 | Icosavax, Inc. | Chief Medical Officer | Form 4 sale | 3,323 | $29k | 1.4% | Routine | SEC |
| Feb 13, 2023 | Feb 15, 2023 | Icosavax, Inc. | Chief Medical Officer | Form 4 sale | 1,794 | $19k | 0.7% | Plan not stated | SEC |
| Jan 4, 2023 | Jan 5, 2024 | Icosavax, Inc. | Chief Medical Officer | Form 4 sale | 106,373 | $1.7M | 32.2% | Unusual | SEC |
| Aug 2, 2022 | Aug 2, 2022 | Icosavax, Inc. | Chief Medical Officer | Form 4 sale | 3,245 | $22k | 1.3% | Plan not stated | SEC |